Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

BIODEXA PHARMACEUTICALS PLC

Company number 09216368

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 7 October 2019
  • GBP 1,020,495.98
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 26 February 2019
  • GBP 1,020,470.98
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 1 August 2018
  • GBP 120,470.98065
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 7 November 2017
  • GBP 102,442.3654
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 16 October 2017
  • GBP 102,442.3654
13 Aug 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 May 2017
  • GBP 1,002,442.3654
12 Aug 2020 SH01 Statement of capital following an allotment of shares on 3 August 2020
  • GBP 1,039,253.557
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
03 Aug 2020 SH01 Statement of capital following an allotment of shares on 22 May 2020
  • GBP 139,253.657001
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
16 Apr 2020 TM01 Termination of appointment of Craig Richard Cook as a director on 31 March 2020
02 Apr 2020 TM01 Termination of appointment of Huaizheng Peng as a director on 31 March 2020
02 Apr 2020 TM01 Termination of appointment of Frederic Duchesne as a director on 31 March 2020
13 Mar 2020 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Consolidation of shares 02/03/2020
12 Mar 2020 SH02 Consolidation of shares on 2 March 2020
12 Mar 2020 SH01 Statement of capital following an allotment of shares on 2 March 2020
  • GBP 123,496.08
  • ANNOTATION Clarification a second filed SH01 was registered on 13/08/2020
14 Feb 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 25 October 2019
  • GBP 123,496.08
14 Feb 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 7 October 2019
  • GBP 120,496.08
07 Feb 2020 SH01 Statement of capital following an allotment of shares on 25 October 2019
  • GBP 2,147,039.767323
  • ANNOTATION Clarification a second filed SH01 was registered on 14/02/2020.
07 Feb 2020 SH01 Statement of capital following an allotment of shares on 7 October 2019
  • GBP 2,147,039.767323
  • ANNOTATION Clarification a second filed SH01 was registered on 14/02/2020.
08 Nov 2019 CS01 Confirmation statement made on 23 October 2019 with updates
  • ANNOTATION Clarification a second filed CS01 (Statement of capital change) was registered on 01/09/2020
08 Nov 2019 PSC02 Notification of A & B (Hk) Company Ltd as a person with significant control on 26 February 2019
08 Nov 2019 PSC02 Notification of Cms Medical Hong Kong Ltd as a person with significant control on 26 February 2019
05 Nov 2019 PSC09 Withdrawal of a person with significant control statement on 5 November 2019
10 Sep 2019 AP01 Appointment of Mr Stephen Anthony Stamp as a director on 9 September 2019
10 Sep 2019 AP03 Appointment of Mr Stephen Anthony Stamp as a secretary on 9 September 2019
10 Sep 2019 TM01 Termination of appointment of Nicholas John Robbins-Cherry as a director on 9 September 2019